Webinar: Canada Rising – The Next Frontier in Clinical Trials

Clinical trials are entering their most turbulent period yet. Rising costs, shifting regulations, geopolitical tensions, and increasingly complex trial designs are reshaping where and how research gets done. Sponsors face mounting pressure from data-heavy studies and shrinking patient pools to supply-chain instability and policy changes that threaten R&D investment.

Amid this disruption, Canada is emerging as a strategic safe haven. Already a top-ten clinical trial destination, and ranking 5th globally for planned trials as of December 2024, Canada offers rare stability, strong regulatory alignment with the EU, and proximity to the world’s largest trial market, the US. As tariffs, policy shifts, and global uncertainty raise risks elsewhere, Canada’s appeal as a cost-effective, reliable research hub is accelerating.

In this new webinar join Zayheda Khan, Oximio’s Chief Commercial Officer and UK Managing Director and Kaitlin Guarasci, Managing Director of Oximio BARL Canada as they explore how global clinical trial pressures are reshaping site selection, why sponsors are rethinking geographic strategy, and where Canada fits into the future of global clinical research.

A must-attend watch for those planning clinical trials in North America delivering practical insights and expert guidance to help navigate logistical challenges within the region.

Discover Oximio’s supply chain solutions for clinical trials in Canada.